Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction
- PMID: 16864723
- DOI: 10.1161/CIRCULATIONAHA.106.632513
Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction
Erratum in
- Circulation. 2006 Sep 12;114(11):e497
Abstract
Background: Cardiac-directed expression of adenylyl cyclase type VI (AC(VI)) in mice results in structurally normal hearts with normal basal heart rate and function but increased responses to catecholamine stimulation. We tested the hypothesis that increased left ventricular (LV) AC(VI) content would increase mortality after acute myocardial infarction (MI).
Methods and results: Transgenic mice with cardiac-directed AC(VI) expression and their transgene-negative littermates (control) underwent coronary ligation, and survival, infarct size, and LV size and function were assessed 1 to 7 days after MI. Mice with increased AC(VI) expression had increased survival (control 41%, AC(VI) 74%; P = 0.004). Infarct size and myocardial apoptotic rates were similar in AC(VI) and control mice; however, AC(VI) mice had less LV dilation (P < 0.001) and increased ejection fractions (P < 0.03). Three days after MI, studies in isolated perfused hearts showed that basal LV +dP/dt was similar, but graded dobutamine infusion was associated with a more robust LV contractile response in AC(VI) mice (P < 0.05). Increased LV function was associated with increases in cAMP generation (P = 0.0002), phospholamban phosphorylation (P < 0.04), sarcoplasmic reticulum Ca2+-ATPase (SERCA2a) affinity for calcium (P < 0.015), and reduced AV block (P = 0.04).
Conclusions: In acute MI, increased cardiac AC(VI) content attenuates adverse LV remodeling, preserves LV contractile function, and reduces mortality.
Comment in
-
Cyclic adenosine monophosphate in acute myocardial infarction with heart failure: slayer or savior?Circulation. 2006 Aug 1;114(5):365-7. doi: 10.1161/CIRCULATIONAHA.106.642132. Circulation. 2006. PMID: 16880340 No abstract available.
Similar articles
-
Adenylyl cyclase type V deletion increases basal left ventricular function and reduces left ventricular contractile responsiveness to beta-adrenergic stimulation.Basic Res Cardiol. 2006 Mar;101(2):117-26. doi: 10.1007/s00395-005-0559-y. Epub 2005 Nov 11. Basic Res Cardiol. 2006. PMID: 16283593
-
Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.Circulation. 2006 Sep 19;114(12):1258-68. doi: 10.1161/CIRCULATIONAHA.106.622415. Epub 2006 Sep 4. Circulation. 2006. PMID: 16952982
-
nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction.Circulation. 2005 Dec 13;112(24):3729-37. doi: 10.1161/CIRCULATIONAHA.105.539437. Circulation. 2005. PMID: 16344403
-
Adenylyl cyclase gene transfer in heart failure.Ann N Y Acad Sci. 2006 Oct;1080:426-36. doi: 10.1196/annals.1380.032. Ann N Y Acad Sci. 2006. PMID: 17132799 Review.
-
Modulation of cAMP: mechanism for positive inotropic action.J Cardiovasc Pharmacol. 1986;8 Suppl 9:S22-9. J Cardiovasc Pharmacol. 1986. PMID: 2433539 Review.
Cited by
-
Gene transfer for congestive heart failure: update 2013.Transl Res. 2013 Apr;161(4):313-20. doi: 10.1016/j.trsl.2012.11.004. Epub 2012 Dec 20. Transl Res. 2013. PMID: 23261978 Free PMC article. Review.
-
Adenylyl cyclase 6 deletion reduces left ventricular hypertrophy, dilation, dysfunction, and fibrosis in pressure-overloaded female mice.J Am Coll Cardiol. 2010 Apr 6;55(14):1476-86. doi: 10.1016/j.jacc.2009.11.066. J Am Coll Cardiol. 2010. PMID: 20359598 Free PMC article.
-
Cellular Signaling for Dental Physiological Functions.Biomolecules. 2023 Jul 28;13(8):1177. doi: 10.3390/biom13081177. Biomolecules. 2023. PMID: 37627242 Free PMC article.
-
Adenylyl cyclase isoforms 5 and 6 in the cardiovascular system: complex regulation and divergent roles.Front Pharmacol. 2024 Apr 3;15:1370506. doi: 10.3389/fphar.2024.1370506. eCollection 2024. Front Pharmacol. 2024. PMID: 38633617 Free PMC article. Review.
-
Regulation of β-Adrenergic Receptors in the Heart: A Review on Emerging Therapeutic Strategies for Heart Failure.Cells. 2024 Oct 10;13(20):1674. doi: 10.3390/cells13201674. Cells. 2024. PMID: 39451192 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous